Hsbc Holdings PLC Raises Holdings in Fulcrum Therapeutics, Inc. (NASDAQ:FULC)
Hsbc Holdings PLC increased its position in Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Free Report) by 55.0% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 75,959 shares of the company’s stock after purchasing an additional 26,944 shares during the period. Hsbc Holdings PLC’s holdings in Fulcrum Therapeutics were worth $355,000 at the end […]
Hsbc Holdings PLC increased its position in Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Free Report) by 55.0% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 75,959 shares of the company’s stock after purchasing an additional 26,944 shares during the period. Hsbc Holdings PLC’s holdings in Fulcrum Therapeutics were worth $355,000 at the end […]
